Crossmark

Synaptic connectomics by sequencing

Crossref DOI link: https://doi.org/10.1038/s41592-026-03052-7

Published Online: 2026-04-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Henry, Gilbert L. https://orcid.org/0000-0003-1590-323X
Zador, Anthony M. https://orcid.org/0000-0002-8431-9136
License Information

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2026-04-01
More Information

Article History

First Online: 1 April 2026

Competing interests

: A.Z. is the founder of Cajal Therapeutics. G.H. declares no competing interests.